[1] Siegel RL, Miller KD, Jemal A.  Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1): 7-30.   doi: 10.3322/caac.21590
[2] 中华医学会核医学分会.  131I治疗分化型甲状腺癌指南(2021版)[J]. 中华核医学与分子影像杂志, 2021, 41(4): 218-241.   doi: 10.3760/cma.j.cn321828-20201113-00412
Chinese Society of Nuclear Medicine.  Guidelines for radioiodine therapy of differentiated thyroid cancer (2021 edition)[J]. Chin J Nucl Med Mol Imaging, 2021, 41(4): 218-241.   doi: 10.3760/cma.j.cn321828-20201113-00412
[3] Tuttle RM, Ahuja S, Avram AM, et al.  Controversies, consensus, and collaboration in the use of 131I therapy in differentiated thyroid cancer: a joint statement from the American thyroid association, the European Association of nuclear medicine, the society of nuclear medicine and molecular imaging, and the European thyroid association[J]. Thyroid, 2019, 29(4): 461-470.   doi: 10.1089/thy.2018.0597
[4] Daniel FI, Lima LD, Grando LJ, et al.  Salivary evaluation in radioactive I131 treated patients with thyroid carcinoma[J]. Acta Odontol Scand, 2018, 76(2): 148-152.   doi: 10.1080/00016357.2017.1399214
[5] Rao D, Behzadi F, Le RT, et al.  Radiation induced mucositis: what the radiologist needs to know[J]. Curr Probl Diagn Radiol, 2021, 50(6): 899-904.   doi: 10.1067/j.cpradiol.2020.10.006

Oh JM, Ahn BC. Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS[J/OL]. Theranostics, 2021, 11(13): 6251−6277[2021-02-23]. https://www.thno.org/v11p6251.htm. DOI: 10.7150/thno.57689.

[7] Thompson RJ, Fletcher A, Brookes K, et al.  Dimerization of the sodium/iodide symporter[J]. Thyroid, 2019, 29(10): 1485-1498.   doi: 10.1089/thy.2019.0034
[8] Sunavala-Dossabhoy G.  Radioactive iodine: an unappreciated threat to salivary gland function[J]. Oral Dis, 2018, 24(1/2): 198-201.   doi: 10.1111/odi.12774
[9] Krcalova E, Horacek J, Gabalec F, et al.  Salivary gland function in thyroid cancer patients with radioiodine administration history[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2020, 164(3): 277-283.   doi: 10.5507/bp.2019.023
[10] Badam RK, Suram J, Babu DBG, et al.  Assessment of salivary gland function using salivary scintigraphy in pre and post radioactive iodine therapy in diagnosed thyroid carcinoma patients[J]. J Clin Diagn Res, 2016, 10(1): ZC60-ZC62.   doi: 10.7860/JCDR/2016/16091.7121
[11] Clement SC, Peeters RP, Ronckers CM, et al.  Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma-a systematic review[J]. Cancer Treat Rev, 2015, 41(10): 925-934.   doi: 10.1016/j.ctrv.2015.09.001
[12] Liu ZJ, Dong LH, Zheng ZZ, et al.  Mechanism, prevention, and treatment of radiation-induced salivary gland injury related to oxidative stress[J]. Antioxidants (Basel), 2021, 10(11): 1666-.   doi: 10.3390/antiox10111666
[13] Henriksson R, Fröjd Ö, Gustafsson H, et al.  Increase in mast cells and hyaluronic acid correlates to radiation-induced damage and loss of serous acinar cells in salivary glands: the parotid and submandibular glands differ in radiation sensitivity[J]. Br J Cancer, 1994, 69(2): 320-326.   doi: 10.1038/bjc.1994.58
[14] Hassan SS, Attia MA, Attia AM, et al.  Distribution of cytokeratin 17 in the parenchymal elements of rat's submandibular glands subjected to fractionated radiotherapy[J]. Eur J Dent, 2020, 14(3): 440-447.   doi: 10.1055/s-0040-1713705
[15] De Paula F, Teshima THN, Hsieh R, et al.  The expression of water channel proteins during human salivary gland development: a topographic study of aquaporins 1, 3 and 5[J]. J Mol Histol, 2017, 48(5/6): 329-336.   doi: 10.1007/s10735-017-9731-6

D'Agostino C, Elkashty OA, Chivasso C, et al. Insight into salivary gland aquaporins[J/OL]. Cells, 2020, 9(6): 1547[2021-02-23]. https://www.mdpi.com/2073-4409/9/6/1547. DOI: 10.3390/cells9061547.

[17] 李审绥, 吴沉洲, 乔翔鹤, 等.  辐射损伤唾液腺机制及治疗的研究进展[J]. 华西口腔医学杂志, 2021, 39(1): 99-104.   doi: 10.7518/hxkq.2021.01.015
Li SS, Wu CZ, Qiao XH, et al.  Advances on mechanism and treatment of salivary gland in radiation injury[J]. West China J Stomatol, 2021, 39(1): 99-104.   doi: 10.7518/hxkq.2021.01.015
[18] 周科, 贾志云.  核素动态显像对131Ⅰ治疗分化型甲状腺癌患者唾液腺损伤程度的评价[J]. 解放军预防医学杂志, 2019, 37(1): 83-85,99.   doi: 10.13704/j.cnki.jyyx.2019.01.025
Zhou K, Jia ZY.  Evaluation of degree of salivary gland injury in differentiated thyroid carcinoma patients treated with 131 Iodine by dynamic radionuclide imaging[J]. J Prev Med Chin Peopl Liber Army, 2019, 37(1): 83-85,99.   doi: 10.13704/j.cnki.jyyx.2019.01.025
[19] Klein Hesselink EN, Brouwers AH, De Jong JR, et al.  Effects of radioiodine treatment on salivary gland function in patients with differentiated thyroid carcinoma: a prospective study[J]. J Nucl Med, 2016, 57(11): 1685-1691.   doi: 10.2967/jnumed.115.169888
[20] Nagler R, Marmary Y, Golan E, et al.  Novel protection strategy against X-ray-induced damage to salivary glands[J]. Radiat Res, 1998, 149(3): 271-276.   doi: 10.2307/3579960
[21] Nagler RM, Baum BJ, Fox PC.  A 2 week pair‐fed study of early X‐irradiation effects on rat major salivary gland function[J]. Arch Oral Biol, 1996, 41(7): 713-717.   doi: 10.1016/S0003-9969(96)00025-8
[22] Kujan O, Othman R, Alshehri M, et al.  Proliferative activity of myoepithelial cells in irradiated rabbit parotid and submandibular salivary glands[J]. J Int Oral Health, 2015, 7(S2): 1-5.
[23] Riachy R, Ghazal N, Haidar MB, et al.  Early sialadenitis after radioactive iodine therapy for differentiated thyroid cancer: prevalence and predictors[J]. Int J Endocrinol, 2020, 2020: 8649794-.   doi: 10.1155/2020/8649794
[24] An YS, Yoon JK, Lee SJ, et al.  Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer[J]. Ann Nucl Med, 2013, 27(4): 386-391.   doi: 10.1007/s12149-013-0697-5
[25] Jeong SY, Kim HW, Lee SW, et al.  Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms[J]. Thyroid, 2013, 23(5): 609-616.   doi: 10.1089/thy.2012.0106
[26] Hyer S, Kong A, Pratt B, et al.  Salivary gland toxicity after radioiodine therapy for thyroid cancer[J]. Clin Oncol (R Coll Radiol), 2007, 19(1): 83-86.   doi: 10.1016/j.clon.2006.11.005
[27] Ou D, Zhang YY, He XY, et al.  Magnetic resonance sialography for investigating major salivary gland duct system after intensity-modulated radiotherapy of nasopharyngeal carcinoma[J]. Int J Clin Oncol, 2013, 18(5): 801-807.   doi: 10.1007/s10147-012-0464-y
[28] Shimada Y, Kojima I, Iikubo M.  Comparative study of multiple high-signal-intensity spots on 3D and 2D magnetic resonance sialography for patients with Sjögren's syndrome[J]. Radiol Res Pract, 2021, 2021: 5846637-.   doi: 10.1155/2021/5846637
[29] Reginelli A, Clemente A, Renzulli M, et al.  Delayed enhancement in differential diagnosis of salivary gland neoplasm[J]. Gland Surg, 2019, 8(S3): S130-S135.   doi: 10.21037/gs.2019.03.03
[30] 谭一清, 张晓磷, 王亚瑟, 等.  颌下腺螺旋CT影像分析[J]. 放射学实践, 2010, 25(1): 37-39.   doi: 10.13609/j.cnki.1000-0313.2010.01.040
Tan YQ, Zhang XL, Wang YS, et al.  Study of imaging anatomy of submandibular gland in normal human beings with multi-slice spiral CT[J]. Radiol Pract, 2010, 25(1): 37-39.   doi: 10.13609/j.cnki.1000-0313.2010.01.040
[31] Afzelius P, Nielsen MY, Ewertsen C, et al.  Imaging of the major salivary glands[J]. Clin Physiol Funct Imaging, 2016, 36(1): 1-10.   doi: 10.1111/cpf.12199
[32] Hong CM, Son SH, Kim CY, et al.  Emptying effect of massage on parotid gland radioiodine content[J]. Nucl Med Commun, 2014, 35(11): 1127-1131.   doi: 10.1097/MNM.0000000000000176
[33] Liu B, Kuang AR, Huang R, et al.  Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial[J]. J Nucl Med, 2010, 51(4): 618-623.   doi: 10.2967/jnumed.109.071449
[34] Charalambous A.  Seeking optimal management for radioactive iodine therapy-induced adverse effects[J]. Asia Pac J Oncol Nurs, 2017, 4(4): 319-322.   doi: 10.4103/apjon.apjon_23_17
[35] Nakada K, Ishibashi T, Takei T, et al.  Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?[J]. J Nucl Med, 2005, 46(2): 261-266.
[36] Haghighatafshar M, Ghaedian M, Etemadi Z, et al.  Pilocarpine effect on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine[J]. Nucl Med Commun, 2018, 39(5): 430-434.   doi: 10.1097/MNM.0000000000000820

Nikles J, Mitchell GK, Hardy J, et al. Do pilocarpine drops help dry mouth in palliative care patients: a protocol for an aggregated series of n-of-1 trials[J/OL]. BMC Palliat Care, 2013, 12(1): 39[2021-02-23]. https://bmcpalliatcare.biomedcentral.com/articles/10.1186/1472-684X-12-39. DOI: 10.1186/1472-684X-12-39.

[38] Varghese JJ, Schmale IL, Mickelsen D, et al.  Localized delivery of amifostine enhances salivary gland radioprotection[J]. J Dent Res, 2018, 97(11): 1252-1259.   doi: 10.1177/0022034518767408
[39] Singh VK, Seed TM.  The efficacy and safety of amifostine for the acute radiation syndrome[J]. Expert Opin Drug Saf, 2019, 18(11): 1077-1090.   doi: 10.1080/14740338.2019.1666104
[40] Lorusso F, Immordino A, Dispenza F, et al.  A conservative treatment for chronic obstructive sialoadenitis by intraductal instillation of mucolytic, steroids and antibiotic solution[J]. Eur Arch Otorhinolaryngol, 2022, 279(1): 501-506.   doi: 10.1007/s00405-021-06930-2
[41] Klinovskaya AS, Gurgenadze AP, Bazikyan EA, et al.  Sialendoscopy in diagnosis and treatment of salivary gland disorders[J]. Stomatologiia (Mosk), 2020, 99(3): 83-86.   doi: 10.17116/stomat20209903183
[42] Frost PM, Shirlaw PJ, Challacombe SJ, et al.  Impact of wearing an intra-oral lubricating device on oral health in dry mouth patients[J]. Oral Dis, 2006, 12(1): 57-62.   doi: 10.1111/j.1601-0825.2005.01161.x
[43] Vinke J, Kaper HJ, Vissink A, et al.  Dry mouth: saliva substitutes which adsorb and modify existing salivary condition films improve oral lubrication[J]. Clin Oral Investig, 2020, 24(11): 4019-4030.   doi: 10.1007/s00784-020-03272-x

Ferreira JNA, Zheng CY, Lombaert IMA, et al. Neurturin gene therapy protects parasympathetic function to prevent irradiation-induced murine salivary gland hypofunction[J/OL]. Mol Ther Methods Clin Dev, 2018, 9: 172−180[2021-02-23]. https://www.cell.com/molecular-therapy-family/methods/fulltext/S2329-0501(18)30020-2?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2329050118300202%3Fshowall%3Dtrue. DOI: 10.1016/j.omtm.2018.02.008.

[45] Alevizos I, Zheng C, Cotrim AP, et al.  Late responses to adenoviral-mediated transfer of the aquaporin-1 gene for radiation-induced salivary hypofunction[J]. Gene Ther, 2017, 24(3): 176-186.   doi: 10.1038/gt.2016.87

Jasmer KJ, Gilman KE, Muñoz Forti K, et al. Radiation-induced salivary gland dysfunction: mechanisms, therapeutics and future directions[J/OL]. J Clin Med, 2020, 9(12): 4095[2021-02-23]. https://www.mdpi.com/2077-0383/9/12/4095. DOI: 10.3390/jcm9124095.